New Strategies for Treatment of Sepsis

• Main Authors: Antonio Mirijello, Alberto Tosoni, on behalf of the Internal Medicine Sepsis Study Group
• Format: Article
• Language: English
• Published: MDPI AG 2020-10-01
• Series: Medicina
• Subjects: internal medicine; intensive care; emergency department; organ dysfunction; immunomodulation; micronutrients
• Online Access: https://www.mdpi.com/1010-660X/56/10/527

Sepsis represents a major global health concern and is one of the most feared complications for hospitalized patients, being the cause, directly or indirectly, of about half of all hospital deaths. According to the last definition, sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection and defined septic shock as a subset of sepsis in which underlying circulatory and cellular/metabolic abnormalities are profound enough to significantly increase mortality. Sepsis is a time-dependent disease and requires a prompt recognition and a standardized treatment. The Special Issue “New Strategies for Treatment of Sepsis” has been thought to connect the experience of physicians involved in the diagnosis, management, and treatment of sepsis at every stage of disease, from emergency departments to general and intensive wards. The focus will be pointed on new approaches to this syndrome, such as early recognition based on clinical features and biomarkers, management in non-ICUs, non-invasive treatment strategies, including non-antimicrobial agents, and, of course, invasive approaches. This Special Issue will highlight the many different facets of sepsis, seen through the eyes of different specialists. We hope to spread the knowledge of a new blueprint for treatment.